...
Drug Information Resident, College of Pharmacy, Washington State University Spokane;
机译:来自II / III期试验的辅助药物的ROLAPITANT的综合安全分析:ROLAPITANT对CYP2D6或BCRP抑制的评估
机译:来自II / III期试验的辅助药物的ROLAPITANT的综合安全分析:ROLAPITANT对CYP2D6或BCRP抑制的评估
机译:Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant
机译:Rolapitant用于预防接受高中度致癌化学疗法的患者的恶心
机译:Rolapitant改善接受高度或中度致癌化学疗法的患者的生活质量